ResourceClinical Diagnostics
Unparalleled precision of SPEAR UltraDetect immunoassays with homogeneous format: GFAP and NfL
15 Jan 2026This application note showcases the exceptional analytical performance of SPEAR UltraDetect™ homogeneous immunoassays for the quantification of the neurological biomarkers GFAP and NfL. Designed to overcome the limitations of conventional ultra-sensitive platforms, SPEAR UltraDetect™ delivers an unprecedented combination of ultra-high sensitivity, superior precision, and robust reproducibility, even at the lowest biomarker concentrations found in blood.